Anticoagulant Monitoring: Patients taking warfarin or other coumarin anticoagulants should have their INR monitored when initiating Wegovy, as changes in absorption may affect anticoagulant activity
Key Takeaways Walking works synergistically with semaglutide, enhancing weight loss results by supporting healthy habits and preserving lean muscle
It mimics endogenous GLP-1, enhancing glucose-dependent insulin secretion, decreasing glucagon secretion, and significantly reducing appetite and energy intake, which leads to clinically meaningful weight loss
Long-term safety data beyond four to five years are still emerging, leaving open questions about sustained muscle preservation, nutrient absorption, and lifelong dependence on medication
But results vary from person to person